Background COVID-19 pandemic has made the disease a major global problem by creating
a significant burden on health, economic, and social status. To date, there are no effective …

Objectives This study aims to investigate the efficacy of curcumin-piperine co-
supplementation on disease duration, severity and clinical symptoms, and inflammatory …

Despite the ongoing vaccination efforts, there is still an urgent need for safe and effective
treatments to help curb the debilitating effects of COVID-19 disease. This systematic review …

Background: Coronavirus disease-2019 (COVID-19) has a wide range of pathophysiological
effects. Curcumin, an active constituent of Curcuma longa (turmeric), has several properties …

The present study conducted a placebo‐controlled clinical trial to evaluate the impact of
nano‐curcumin on the inflammatory cytokines in mild‐to‐moderate hospitalized COVID‐19 …

Background Curcumin, a natural polyphenolic compound, is proposed as a potential
treatment option for patients with coronavirus disease by inhibiting the entry of virus to the …

The main aim of the current study was to summarize the findings of available clinical studies
to assess nano‐curcumin's influence on COVID patients. A comprehensive online search …

Curcumin is a low‐cost and easily accessible therapeutic option for COVID‐19 patients. We
aimed to conduct a meta‐analysis to assess the effect of curcumin on clinical outcomes in …

Different immunomodulation strategies have been used to manage COVID‐19 due to the
complex immune‐inflammatory processes involved in the pathogenesis of this infection …

Curcumin is proposed as a potential treatment option for coronavirus disease‐19 (COVID‐
19) by inhibiting the virus entrance, encapsulation and replication, and modulating various …